Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use. Plus, gain insights on building effective communication strategies, data-driven storytelling, and explore Scotland’s storied role in the history of medical innovation.
A history of: Scottish medical innovation
From grave robbers and penicillin to robotic limbs and cloned sheep, Scotland has lent a hand to some of history’s most important medical innovations. Deep Dive editor Eloise McLennan tracks the most influential discoveries to emerge from the land of the brave.
The Ozempic dilemma: Balancing demand, supply, and patient safety in a viral GLP-1 World
Soaring demand for Ozempic and GLP-1s, driven by trend-fuelled off-label interest, has exposed serious weaknesses in the supply chain, and opened the door for counterfeiters to exploit desperate patients, putting both their health and finances at risk.
Five top tips for developing a communication strategy
Developing and executing the right communication strategy is an exact science, so how can young life sciences companies avoid missing the mark? IB Communications CEO Michelle Boxall shares five ideas to help assemble an effective media strategy.
Accelerating pharma marketing: Mastering content velocity for maximum impact
How can pharmaceutical companies master content velocity to deliver brand content with unparalleled speed, precision, and reach? EVERSANA INTOUCH’s Angela Tenuta examines the three fundamental pillars required to deliver relevant, personalised content at speed.
The Big Interview: Measuring the impact of medical affairs
Christoph Bug, vice president of global medical at Veeva, and Pascal Vande Gucht, medical excellence transformation lead at UCB, share their perspectives on the trends, challenges, and opportunities shaping the future of medical affairs.
ChatGPT will write your brand story if you don’t (and four more AI insights from Future Pharma)
GenAI has certainly been a hot topic for the industry in 2024, but as speakers at this year’s Future Pharma event in Boston explained, ignoring the growing market is no longer an option for pharma marketers. pharmaphorum editor-in-chief, Jonah Comstock, reports.
Beyond the science: Crafting compelling stories with data-driven medical communications
Well-crafted storytelling can transform medical communications from dense scientific data into impactful narratives that resonate with your audience. Here, Adam Goodband from Enzyme Communications details how data can be used to unlock the power of storytelling.
Assessing the global applicability of the UK’s ‘Netflix’-style subscription model for antibiotics
With the UK’s innovative subscription model now a permanent feature of the nation’s antibiotics strategy, Nicole Raleigh examines whether the project could find success elsewhere.
Read Deep Dive: Commercialisation in full pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Subscribe to future issues of Deep Dive.
